Your browser doesn't support javascript.
loading
Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F.
Adams, Ralph; Maroof, Asher; Baker, Terry; Lawson, Alastair D G; Oliver, Ruth; Paveley, Ross; Rapecki, Steve; Shaw, Stevan; Vajjah, Pavan; West, Shauna; Griffiths, Meryn.
Afiliação
  • Adams R; Discovery Science, New Modality Therapeutics, UCB Pharma, Slough, United Kingdom.
  • Maroof A; Immuno-Bone Therapeutic Area, Immunology Research, UCB Pharma, Slough, United Kingdom.
  • Baker T; Discovery Science, New Modality Therapeutics, UCB Pharma, Slough, United Kingdom.
  • Lawson ADG; Research Fellow, UCB Pharma, Slough, United Kingdom.
  • Oliver R; Development Science, QP/DMPK, UCB Pharma, Slough, United Kingdom.
  • Paveley R; Immuno-Bone Therapeutic Area, Immuno-Bone Discovery, UCB Pharma, Slough, United Kingdom.
  • Rapecki S; Discovery Science, New Modality Therapeutics, UCB Pharma, Slough, United Kingdom.
  • Shaw S; Immuno-Bone Therapeutic Area, Immunology Research, UCB Pharma, Slough, United Kingdom.
  • Vajjah P; Development Science, QP/DMPK, UCB Pharma, Slough, United Kingdom.
  • West S; Immuno-Bone Therapeutic Area, Immuno-Bone Discovery, UCB Pharma, Slough, United Kingdom.
  • Griffiths M; Translational Medicine, TM Immuno-Bone, UCB Pharma, Slough, United Kingdom.
Front Immunol ; 11: 1894, 2020.
Article em En | MEDLINE | ID: mdl-32973785
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-17 / Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / Anti-Inflamatórios Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-17 / Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / Anti-Inflamatórios Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido